Quick Answer
Aurinia Pharmaceuticals Inc. reported Total Assets of $751.59 million for fiscal year 2025.
Aurinia Pharmaceuticals Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $751.59M | +36.5% |
| 2024 | $550.64M | +0.5% |
| 2023 | $548.06M | +16.4% |
| 2022 | $470.86M | -13.3% |
| 2021 | $543.37M | +17.2% |
| 2020 | $463.66M | +43.0% |
| 2019 | $324.30M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $527.53M | -4.0% | +5.0% |
| June 30, 2025 | $502.56M | -4.0% | -0.5% |
| March 31, 2025 | $504.85M | -2.3% | -8.3% |
| December 31, 2024 | $550.64M | +0.5% | +0.2% |
| September 30, 2024 | $549.36M | -1.0% | +4.9% |
| June 30, 2024 | $523.53M | -4.6% | +1.3% |
| March 31, 2024 | $516.63M | +14.4% | -5.7% |
| December 31, 2023 | $548.06M | +16.4% | -1.3% |
- Aurinia Pharmaceuticals Inc. showed an increase of +36.5% in Total Assets compared to the prior fiscal year.
- Over the 2019–2025 period, Aurinia Pharmaceuticals Inc.’s total assets has grown by 131.8% (from $324.30 million to $751.59 million).
- The most recent figure is from Aurinia Pharmaceuticals Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: